Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference Transcript
All right. Let's get started. Thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here. It's my pleasure to introduce the team from Blueprint Medicine, short one, but that's okay. To my left is Christy Rossi, Chief Operating Officer; and Fouad Namouni, President of R&D. And just a reminder, format for today is a fireside chat. We'll keep it informal. If anyone has a question in the audience, please feel free to raise your hand, and we'll move that into the conversation. Before we get started, I just need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
With that, I'll just turn it over to Christy to give us some introductory comments and then we can operate into the Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
